HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.
Los Angelas, CA -- (SBWIRE) -- 09/10/2012 -- Peregrine Pharmac (NCM:PPHM) is very active today and traded between $2.68 - 5.08 with total traded volume of 29297604 shares. At a current price of 4.50, PPHM is +1.43 - +46.58% from the previous close of $3.07. Moreover, At Current Market Price, PPHM is in distance of +96.24% from its 50-day Moving Average price of $2.2931 and +337.62% from its 200-day Moving Average price of $1.0283. Shares of Peregrine Pharmaceuticals Inc. gain almost half their value on word that its interim results Phase II trials showed that the combined use of its bavituximab drug candidate with chemotherapy drug docetaxel caused a statistically significant improvement in the overall survival rate for lung cancer patients. The trial is evaluating the overall response rate of the chemotherapy drugs with or without bavituximab in patients with refractory nonsmall cell lung cancer.Shares rose 11% to $3.41 before being halted prior to the data release. The company is presenting its results at the 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology Friday afternoon. The company is planning for an end-of-phase II meeting with the U.S. Food and Drug Administration and plans to initiate a phase III trial by mid-2013.Chief Executive Steven W. King said the firm is currently in discussions with several potential pharmaceutical partners who have expressed great interest in the bavituximab oncology program. Peregrine also is evaluating bavituximab, a phosphyatidylserine-targeting monoclonal antibody, as a potential treatment of hepatitis C and pancreatic cancer.
How Should Investors Trade PPHM Now? Find Out Here
BioFuel Energy Co (NCM:BIOF) is +1.71 - +57.00% from the previous close of $3.00. It traded between $3.22 - 5.89 with total traded volume of 1703197 shares. At Current Market Price, BIOF is in distance of +56.39% from its 50-day Moving Average price of $3.0117 and -36.41% from its 200-day Moving Average price of $7.4065. A big jump in BioFuel Energy (BIOF) demonstrates the market-moving power of prominent investors. After hedge fund manager David Einhorn raised his stake in the ethanol maker by 11%, BioFuel Energy surged 61.33% to $4.84. Prior to Friday, shares of Biofuel were down 76% year-to-date because of a US drought-related corn supply squeeze.
Can BIOF Recover After The Recent fall? Find Out Here
Cell Therapeutics (NCM:CTIC) reported EPS of -3.126. For the Current Fiscal year, the company is expected to report EPS of -3.00. For the Next Quarter and Next Year, the company is expected to report EPS of -0.50 and -2.50 respectively. At Current Market Price, CTIC is in distance of +2.55% from its 50-day Moving Average price of $2.2623 and -46.85% from its 200-day Moving Average price of $4.3649. Cell Therapeutics, Inc. develops, acquires and commercializes novel treatments for cancer. It researches, development, acquisition and in-licensing activities concentrate on identifying and developing new, less toxic and effective ways to treat cancer.
Can CTIC Recover After The Recent fall? Find Out Here
lululemon athleti (NasdaqNM:LULU) is very active today and traded between $67.10 - 77.60 with total traded volume of 17133550 shares. At a current price of 77.14, LULU is +8.54 - +12.45% from the previous close of $68.60. Moreover, At Current Market Price, LULU is in distance of +26.33% from its 50-day Moving Average price of $61.0617 and +15.14% from its 200-day Moving Average price of $66.9977. Lululemon athletica inc. (LULU) reported another wonderful quarter of sales and earnings growth during its Q2 2012 conference call on Friday, September 7th. After initially opening down 2%, the stock rallied and finished the day with a gain of more than 12%. Revenue increased 33% YOY to $282.6 million, driven by a combination of 15% comparable store sales growth, a 91% increase in direct-to-consumer sales and the addition of 38 new locations that opened over the last 12 months (bringing the total to 189 stores worldwide). Management reported EPS of $0.39, which included a one-time tax benefit of $0.05 per share. (When an adjustment is made for the one-time tax benefit EPS grew 31% YOY to $0.34 per share.)
How Should Investors Trade LULU Now? Find Out Here
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)